Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page
- Check4 days agoChange DetectedNo changes were detected in the provided additions/deletions inputs.SummaryDifference0.0%

- Check11 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoChange DetectedIQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check47 days agoChange DetectedStudy Protocol and SAP documents updated to revision v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.2 was added, and the notice about a lapse in government funding as well as the previous Revision: v3.4.1 were removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.